Erlotinib: new indication. Metastatic cancer of the pancreas: palliative care is still the best option.
D017277:Drug Approval; D005060:Europe; D006801:Humans; D009362:Neoplasm Metastasis / Q000628:therapy; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000628:therapy; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D011799:Quinazolines